BYVASDA
Live / Registered — Registered (as of 17 Aug 2021)
What this means for you
Registered since 17 Aug 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 17 Aug 2027, and its filing window is open now).
Record
- Serial number
- 79301072
- Registration number
- 6451085
- Mark type
- Stylized text
- Filed
- 25 Nov 2020
- Published for opposition
- 01 Jun 2021
- Registered
- 17 Aug 2021
- Next maintenance filing
- §71 affidavit of use, due by 17 Aug 2027 (grace period to 17 Feb 2028)
- Attorney of record
- Paulo A. de Almeida
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of cancer for human purposes; biochemical medicines for the treatment of cancer; liquid medicines for the treatment of cancer; blood products, namely, blood plasma, blood for medical purposes; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer for medical purposes; biological tissue cultures for veterinary purposes; drugs for the treatment of cancer for medical purposes; diagnostic preparations for medical purposes; vaccines; injectable pharmaceuticals for treatment of anaphylactic reactions
Owner
Prosecution history
- 17 Aug 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 20 Feb 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Feb 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 02 Feb 2022 — FINAL DISPOSITION PROCESSED
- 17 Nov 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jun 2021 — PUBLISHED FOR OPPOSITION
- 12 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Feb 2021 — REFUSAL PROCESSED BY IB
- 03 Feb 2021 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB